Addex Therapeutics Ltd. SEC filings ADXN
Addex Therapeutics Ltd. has 279 filings in SEC EDGAR's recent list, going back to Sep 24, 2019. Its latest annual report, Form 20-F, was filed on May 15, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 29, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 29, 2026 | Oct 29, 2026 |
| 6-K | Current report (foreign issuer) | Oct 8, 2026 | Oct 8, 2026 |
| 6-K | Current report (foreign issuer) | Oct 2, 2026 | Oct 2, 2026 |
| 6-K | Current report (foreign issuer) | Sep 28, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Sep 25, 2026 | Sep 25, 2026 |
| 6-K | Current report (foreign issuer) | Aug 26, 2026 | Aug 26, 2026 |
| 6-K | Current report (foreign issuer) | Jul 8, 2026 | Jul 8, 2026 |
| 6-K | Current report (foreign issuer) | Jun 30, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Jun 25, 2026 | Jun 25, 2026 |
| 6-K | Current report (foreign issuer) | Jun 5, 2026 | Jun 5, 2026 |
| 6-K | Current report (foreign issuer) | Apr 30, 2026 | Apr 30, 2026 |
| 6-K | Current report (foreign issuer) | Apr 29, 2026 | Apr 29, 2026 |
| 6-K | Current report (foreign issuer) | Apr 23, 2026 | Apr 23, 2026 |
| 6-K | Current report (foreign issuer) | Apr 21, 2026 | Apr 21, 2026 |
| 6-K | Current report (foreign issuer) | Feb 3, 2026 | Feb 3, 2026 |
| 6-K | Current report (foreign issuer) | Jan 7, 2026 | Jan 7, 2026 |
| 6-K | Current report (foreign issuer) | Dec 10, 2025 | Dec 10, 2025 |
| 6-K | Current report (foreign issuer) | Dec 4, 2025 | Dec 4, 2025 |
| 6-K | Current report (foreign issuer) | Oct 29, 2025 | Oct 29, 2025 |
| 6-K | Current report (foreign issuer) | Sep 30, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Sep 23, 2025 | Sep 23, 2025 |
| 6-K | Current report (foreign issuer) | Jun 30, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Jun 25, 2025 | Jun 25, 2025 |
| 6-K | Current report (foreign issuer) | Jun 20, 2025 | Jun 20, 2025 |
| 6-K | Current report (foreign issuer) | Jun 6, 2025 | Jun 6, 2025 |
| 6-K | Current report (foreign issuer) | May 12, 2025 | May 12, 2025 |
| 6-K | Current report (foreign issuer) | Apr 30, 2025 | Apr 30, 2025 |
| 6-K | Current report (foreign issuer) | Apr 25, 2025 | Apr 25, 2025 |
| 6-K | Current report (foreign issuer) | Apr 17, 2025 | Apr 17, 2025 |
| 6-K | Current report (foreign issuer) | Nov 22, 2024 | Nov 22, 2024 |
| 6-K | Current report (foreign issuer) | Nov 12, 2024 | Nov 11, 2024 |
| 6-K | Current report (foreign issuer) | Sep 30, 2024 | Sep 30, 2024 |
| 6-K | Current report (foreign issuer) | Sep 19, 2024 | Sep 19, 2024 |
| 6-K | Current report (foreign issuer) | Aug 27, 2024 | Aug 27, 2024 |
| 6-K | Current report (foreign issuer) | Jul 22, 2024 | Jul 22, 2024 |
| 6-K | Current report (foreign issuer) | Jul 15, 2024 | Jul 15, 2024 |
| 6-K | Current report (foreign issuer) | Jul 1, 2024 | Jul 1, 2024 |
| 6-K | Current report (foreign issuer) | Jun 6, 2024 | Jun 6, 2024 |
| 6-K | Current report (foreign issuer) | Jun 5, 2024 | Jun 5, 2024 |
| 6-K | Current report (foreign issuer) | Apr 29, 2024 | Apr 29, 2024 |
| 6-K | Current report (foreign issuer) | Apr 18, 2024 | Apr 18, 2024 |
| 6-K | Current report (foreign issuer) | Apr 3, 2024 | Apr 3, 2024 |
| 6-K | Current report (foreign issuer) | Jan 30, 2024 | Jan 30, 2024 |
| 6-K/A | Form 6-k/a | Dec 21, 2023 | Jun 30, 2023 |
| 6-K | Current report (foreign issuer) | Dec 20, 2023 | Dec 20, 2023 |
| 6-K | Current report (foreign issuer) | Dec 14, 2023 | Dec 14, 2023 |
| 6-K | Current report (foreign issuer) | Nov 29, 2023 | Nov 29, 2023 |
| 6-K | Current report (foreign issuer) | Nov 28, 2023 | Nov 28, 2023 |
| 6-K | Current report (foreign issuer) | Nov 14, 2023 | Nov 14, 2023 |
| 6-K | Current report (foreign issuer) | Nov 8, 2023 | Nov 8, 2023 |
| 6-K | Current report (foreign issuer) | Oct 20, 2023 | Oct 20, 2023 |
| 6-K | Current report (foreign issuer) | Oct 6, 2023 | Oct 6, 2023 |
| 6-K | Current report (foreign issuer) | Sep 20, 2023 | Sep 20, 2023 |
| 6-K | Current report (foreign issuer) | Sep 5, 2023 | Sep 5, 2023 |
| 6-K | Current report (foreign issuer) | Sep 5, 2023 | Sep 4, 2023 |
| 6-K | Current report (foreign issuer) | Aug 10, 2023 | Aug 10, 2023 |
| 6-K | Current report (foreign issuer) | Aug 3, 2023 | Aug 3, 2023 |
| 6-K | Current report (foreign issuer) | Jul 24, 2023 | Jul 24, 2023 |
| 6-K | Current report (foreign issuer) | Jun 15, 2023 | Jun 15, 2023 |
| 6-K | Current report (foreign issuer) | Jun 1, 2023 | Jun 1, 2023 |
| 6-K | Current report (foreign issuer) | May 18, 2023 | May 18, 2023 |
| 6-K | Current report (foreign issuer) | May 11, 2023 | May 11, 2023 |
| 6-K | Current report (foreign issuer) | May 10, 2023 | May 10, 2023 |
| 6-K | Current report (foreign issuer) | May 5, 2023 | May 5, 2023 |
| 6-K | Current report (foreign issuer) | Apr 4, 2023 | Apr 4, 2023 |
| 6-K | Current report (foreign issuer) | Apr 4, 2023 | Apr 4, 2023 |
| 6-K | Current report (foreign issuer) | Apr 3, 2023 | Apr 3, 2023 |
| 6-K | Current report (foreign issuer) | Mar 30, 2023 | Mar 30, 2023 |
| 6-K | Current report (foreign issuer) | Feb 9, 2023 | Feb 9, 2023 |
| 6-K | Current report (foreign issuer) | Feb 6, 2023 | Feb 6, 2023 |
| 6-K | Current report (foreign issuer) | Jan 19, 2023 | Jan 19, 2023 |
| 6-K | Current report (foreign issuer) | Dec 8, 2022 | Dec 8, 2022 |
| 6-K | Current report (foreign issuer) | Nov 14, 2022 | Nov 14, 2022 |
| 6-K | Current report (foreign issuer) | Nov 3, 2022 | Nov 3, 2022 |
| 6-K | Current report (foreign issuer) | Nov 1, 2022 | Nov 1, 2022 |
| 6-K/A | Form 6-k/a | Sep 14, 2022 | Jun 30, 2022 |
| 6-K | Current report (foreign issuer) | Aug 18, 2022 | Aug 18, 2022 |
| 6-K | Current report (foreign issuer) | Aug 15, 2022 | Aug 15, 2022 |
| 6-K | Current report (foreign issuer) | Jul 26, 2022 | Jul 26, 2022 |
| 6-K | Current report (foreign issuer) | Jul 22, 2022 | Jul 22, 2022 |
| 6-K | Current report (foreign issuer) | Jul 21, 2022 | Jul 21, 2022 |
| 6-K | Current report (foreign issuer) | Jul 21, 2022 | Jul 21, 2022 |
| 6-K | Current report (foreign issuer) | Jun 17, 2022 | Jun 17, 2022 |
| 6-K | Current report (foreign issuer) | May 27, 2022 | May 27, 2022 |
| 6-K | Current report (foreign issuer) | May 10, 2022 | May 10, 2022 |
| 6-K | Current report (foreign issuer) | May 5, 2022 | May 5, 2022 |
| 6-K | Current report (foreign issuer) | Apr 13, 2022 | Apr 13, 2022 |
| 6-K | Current report (foreign issuer) | Apr 6, 2022 | Apr 6, 2022 |
| 6-K | Current report (foreign issuer) | Mar 31, 2022 | Mar 31, 2022 |
| 6-K | Current report (foreign issuer) | Mar 10, 2022 | Mar 10, 2022 |
| 6-K | Current report (foreign issuer) | Feb 3, 2022 | Feb 3, 2022 |
| 6-K | Current report (foreign issuer) | Dec 20, 2021 | Dec 17, 2021 |
| 6-K | Current report (foreign issuer) | Dec 15, 2021 | Dec 15, 2021 |
| 6-K | Current report (foreign issuer) | Nov 15, 2021 | Nov 15, 2021 |
| 6-K | Current report (foreign issuer) | Nov 4, 2021 | Nov 4, 2021 |
| 6-K | Current report (foreign issuer) | Sep 29, 2021 | Sep 29, 2021 |
| 6-K | Current report (foreign issuer) | Sep 22, 2021 | Sep 22, 2021 |
| 6-K | Current report (foreign issuer) | Aug 5, 2021 | Aug 5, 2021 |
| 6-K | Current report (foreign issuer) | Aug 2, 2021 | Aug 2, 2021 |
| 6-K | Current report (foreign issuer) | Jul 29, 2021 | Jul 29, 2021 |
| 6-K | Current report (foreign issuer) | Jul 1, 2021 | Jul 1, 2021 |
| 6-K | Current report (foreign issuer) | Jun 30, 2021 | Jun 29, 2021 |
| 6-K | Current report (foreign issuer) | Jun 29, 2021 | Jun 29, 2021 |
| 6-K | Current report (foreign issuer) | Jun 17, 2021 | Jun 17, 2021 |
| 6-K | Current report (foreign issuer) | Jun 7, 2021 | Jun 7, 2021 |
| 6-K | Current report (foreign issuer) | May 17, 2021 | May 17, 2021 |
| 6-K | Current report (foreign issuer) | May 14, 2021 | May 14, 2021 |
| 6-K | Current report (foreign issuer) | May 5, 2021 | May 5, 2021 |
| 6-K | Current report (foreign issuer) | Apr 26, 2021 | Apr 26, 2021 |
| 6-K | Current report (foreign issuer) | Apr 8, 2021 | Apr 8, 2021 |
| 6-K | Current report (foreign issuer) | Mar 11, 2021 | Mar 11, 2021 |
| 6-K | Current report (foreign issuer) | Feb 17, 2021 | Feb 17, 2021 |
| 6-K | Current report (foreign issuer) | Feb 16, 2021 | Feb 16, 2021 |
| 6-K | Current report (foreign issuer) | Jan 21, 2021 | Jan 21, 2021 |
| 6-K | Current report (foreign issuer) | Jan 12, 2021 | Jan 11, 2021 |
| 6-K | Current report (foreign issuer) | Jan 7, 2021 | Jan 7, 2021 |
| 6-K | Current report (foreign issuer) | Dec 14, 2020 | Dec 14, 2020 |
| 6-K | Current report (foreign issuer) | Nov 3, 2020 | Nov 3, 2020 |
| 6-K | Current report (foreign issuer) | Nov 2, 2020 | Nov 2, 2020 |
| 6-K | Current report (foreign issuer) | Aug 27, 2020 | Aug 27, 2020 |
| 6-K | Current report (foreign issuer) | Aug 12, 2020 | Aug 12, 2020 |
| 6-K | Current report (foreign issuer) | Jul 20, 2020 | Jul 20, 2020 |
| 6-K | Current report (foreign issuer) | Jun 16, 2020 | Jun 16, 2020 |
| 6-K | Current report (foreign issuer) | Jun 10, 2020 | Jun 10, 2020 |
| 6-K | Current report (foreign issuer) | May 20, 2020 | May 20, 2020 |
| 6-K | Current report (foreign issuer) | May 19, 2020 | May 19, 2020 |
| 6-K | Current report (foreign issuer) | Apr 8, 2020 | Apr 8, 2020 |
| 6-K | Current report (foreign issuer) | Mar 18, 2020 | Mar 18, 2020 |
| 6-K | Current report (foreign issuer) | Mar 6, 2020 | Mar 3, 2020 |
Showing 129 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ADXN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Switzerland
- Headquarters
- Geneva, Switzerland
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1574232
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.